Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Items 801–875 of 875
Novel aspects of TGFβ in human CD4 + T cell biology
Bonn, R. F.-W.-U. (2008)
Cellules dendritiques tueuses ou cellules NK présentatrices d'antigènes ?
Zitvogel, L., Mignot, G., Bonmort, M., Ullrich, E., & Chaput, N. (2008)
FOXP3 and CTLA-4 : how isoforms regulate immunological tolerance
Liu, S. (2015) · Figshare
Galani, I. E. (2008) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00008497
Humblet‐Baron, S. (2009) · ORBi (University of Liège)
Lammers, S. S., Ukena, S. N., Velaga, S., & Franzke, A. (2013) · Experimental and Clinical Transplantation · doi:10.6002/ect.2012.0187
Lü, C.-X., & Zhang, C. (2013) · Heart · doi:10.1136/heartjnl-2013-304613.272
“T conv, with transient FOXP3-expression, do not exhibit suppressor function, the hallmark characteristics of FOXP3þTregs and can even produce pro-inflammatory cytokines [18,19].”
BackgroundHimmel, M. E. (2012) · cIRcle (University of British Columbia) · doi:10.14288/1.0072834
“…associated markers such as CD25, FOXP3, glucocorticoid induced tumor necrosis factor receptor (GITR), and CTLA-4 are upregulated in conventional T cells upon activation (Allan et al., 2007) making it difficult to distinguish Tregs from activated effector cells particularly in a disease setting.”
BackgroundChernykh, E. R., Kurganova, E. V., Tikhonova, M. A., Laskavaya, E. G., Лебедева, В. А., & Ostanin, A. A. (2010)
Silva-Barbosa, S. D., Augusto, Â. D. R., Maueia, C., Mabunda, N. J., Samo, E., Gudo, Bhatt, N., Jani, I. V., & Savino, W. (2015)
Eastaff‐Leung, N. (2009) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 1
Modulation von T-Zell-Funktionen durch Aktivierung von TNFR2 mit Fokus auf regulatorische T-Zellen
Immunologie, F., Männel, D. N., & Medizin, F. F. (2015)
Post-translational regulation of FOXP3
Coffer, P. J., Prakken, A. B. J., & van Loosdregt, J. (2006)
Small-molecules as regulatory T cell modulators: A pilot screen
Sirkiä, M. (2008) · Tampere University Institutional Repository (Tampere University)
de Almeida, A. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-04082017-103556
Cellular Therapy in Transplantation and Tolerance
Mason, G. M., Patel, J. J., Halim, L., Safinia, N., & Lombardi, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-62142-5_6
Intrinsic Mechanisms Regulating T Cell Tolerance in Autoimmune Diabetes
Zhang, Q. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
The role of invariant Natural Killer T cells in SLE patients with atherosclerosis
Smith, E. C. (2016) · UCL Discovery (University College London) · Cited by 1
T regulatory cell therapy in preclinical and clinical pancreatic islet transplantation
Fousteri, G., & Cicalese, M. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00063-0
Congenital Immune Dysregulation Disorders
Fleisher, T. A., Oliveira, J. B., & Torgerson, T. R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0271-2.00015-8
Clinical Significance of Foxp3 Gene Expression in Patients with Lupus Nephritis
Aleem, A. A., Attia, F. M., Omar, A. S., & Hassan, R. (2016) · Suez Canal University Medical Journal · doi:10.21608/scumj.2016.116297
Wang, J. (2011) · Leiden Repository (Leiden University)
YangYong-jun, Y., Tang, L.-T., Li, Y., Cao, Y.-Q., ZhangXin-xin, J.-H., & Mao, W.-Z. (2013)
Lentivirus-mediated knockdown of Galectin-10 and Foxp3 in human immune cells
Zidan, M. H. (2013) · Gutenberg Open Science · doi:10.25358/openscience-2749
CD127 expression in peripheral T cells of pediatric kidney transplant recipients
Salah, D. M., Elshamaa, M. F., Elghoroury, E. A., Kassem, N. M. A., Bazaraa, H. M., Ibrahim, M. F., Galal, A., & Fadel, F. I. (2021) · Pediatria Polska · doi:10.5114/polp.2021.109302
“On the other hand, Foxp3 induced by activation in effector T cells is not sufficient to permanently suppress CD127 expression in these cells and after the initial, post-activation decline of CD127 expression in Teff cells CD127 is reconstituted [6, 20].”
BackgroundSchönfeld, E. (2012) · bonndoc (University of Bonn)
Hu, L., Zhu, M., Shen, Y., Zhong, Z., & Wu, B. Y. (2021) · Research Square · doi:10.21203/rs.3.rs-651950/v1
Large-Scale Gene Expression in Monogenic and Complex Genetic Diseases
Wolff, A. S. B., Handel, A. E., & Oftedal, B. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87821-4_16
The Role of T Regulatory Cells in Immune Senescence
Moss, P. A. H. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_10
Rowe, J., Stadinski, B. D., Henderson, L., de Bruin, L. M. O., Delmonte, O., Lee, Y., de la Morena, M., Goyal, R., Hayward, A. R., Chiung-Hui, H., et al. (2018) · immuneACCESS · doi:10.21417/b7j911
Designing Strategies to Improve the T Cell Mediated Immunotherapy of Mouse Tumours.
Ataera, H. (2009) · doi:10.26686/wgtn.16969756
“.......................................................................................................................... 113 Figure 4.6: A single 100 µg dose of PC61 is sufficient to reduce the frequency of both CD25+ and Foxp3+ cells in the blood for a prolonged period of time....................... 115 Figure 4.7:…”
BackgroundMethodResultInfluentialUsing Natural Adjuvants to Stimulate Anti-Tumour Immune Responses
Kuhn, S. P. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17011490
Podestà, M., van Binder, C., Sellberg, F., Dewolf, S., Shonts, B. A., Ho, S., Obradovic, A., Waffarn, E., Danzl, N. M., Berglund, D., et al. (2019) · immuneACCESS · doi:10.21417/mp2019ajt
Positive and negative selection shape the human naïve B cell repertoire
Chen, J., Schickel, J., Tsakiris, N., Sng, J., Arbogast, F., Bouis, D., Parisi, D., Gera, R., Boeckers, J. M., Delmontte, F., et al. (2021) · immuneACCESS · doi:10.21417/jwc2021jci
DNA methylation in blood - potential to provide new insights in immune cell biologyPreprint
Macartney-Coxson, D. P., Cameron, A. M., Clapham, J., & Benton, M. C. (2019) · Research Square · doi:10.21203/rs.2.13274/v1
The Role of T Regulatory Cells in Immune Senescence
Moss, P. A. H. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_10-1
Li, S., Floess, S., Hamann, A., Gaudieri, S., Lucas, A., Hellard, M. E., Roberts, S. K., Paukovic, G., Plebanski, M., Loveland, B. E., et al. (2012) · PLoS Pathogens · doi:10.1371/annotation/523d94fe-9730-499b-95b1-addd94089ff8
Data from The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
Ebert, L. M., Tan, B. S., Browning, J., Svobodová, S., Russell, S. E., Kirkpatrick, N., Gedye, C. A., Moss, D. J., Ng, S. P., MacGregor, D. P., et al. (2023) · doi:10.1158/0008-5472.c.6497534
Data from FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
Kryczek, I., Liu, R., Wang, G., Wu, K., Shu, X., Szeliga, W., Vatan, L., Finlayson, E. V. A., Huang, E. H., Simeone, D. M., et al. (2023) · doi:10.1158/0008-5472.c.6499863.v1
Detect the Amount of CD4+ Foxp3+ T-regulatory (Treg) Cell in Iraqi Patients with Behcet’s Disease
AL-Tai, T. H. H., Al-Hadithi, H. S., & AL-Yasiry, D. S. (2022) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.13.2.29
Role of regulatory T cells in pathogenesis and therapeutics of multiple sclerosis
Szpakowski, P., Ksiazek-Winiarek, D. J., & Glabinski, A. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13947-5.00041-5
Zarrinrad, G., Burkhardt, L.-M., Wagner, D. L., Schlickeiser, S., Stein, M., Wendering, D. J., Ehlen, L., Kurgan, G., Durek, P., Heinrich, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.10.693159
Regin in Blood Immune Regulation in Type 1 Diabetes
Pihl, M. (2013) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-98250
Koll, F. J., Banek, S., Kluth, L., Köllermann, J. W., Bankov, K., Chun, F. K. ‐., Wild, P., Weigert, A., & Reis, H. (2024) · Figshare · doi:10.6084/m9.figshare.26568754
Alfaar, A. S., Stürzbecher, L., Diedrichs‐Möhring, M., Lam, M., Roubeix, C., Ritter, J., Schumann, K., Annamalai, B., Pompös, I.-M., Rohrer, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21384335
Simonetta, F. (2011) · theses.fr (ABES) · doi:10.70675/032c421dzd23ez4b4aza677z79cae2e44063
Zheng, S. G. (2011) · theses.fr (ABES) · doi:10.70675/5d2c9181z484ez48e4z8069zbb0944794da6
Potentiel thérapeutique des lymphocytes régulateurs de type 1 (Tr1) dans l'arthrite expérimentale.
Martire, D. (2013) · theses.fr (ABES) · doi:10.70675/b63af179z4fd3z47d1z9a6ez42df33c95b34
Hamdani, S. (2016) · theses.fr (ABES) · doi:10.70675/9e24450czb094z4495zafbfz117b8e3adf32
Génération et analyse d’un nouveau modèle de la maladie APECED par déficience pour Aire chez le rat
Ossart, J. (2018) · theses.fr (ABES) · doi:10.70675/96586792zd58bz497dza907zfe0a41d8d94d
Santinon, F. (2018) · theses.fr (ABES) · doi:10.70675/4491fdebz295cz483bz93afz9cd31ce39645
Targeting the metabolic environment to modulate T cell effector function
Matias, M. I. (2019) · theses.fr (ABES) · doi:10.70675/0582ddaaze61dz4707z9cb1zdb8fe1d82653
Rôle du TNFR2 exprimé par les lymphocytes T régulateurs au cours de l'immunodépression post septique
Gaborit, B. (2019) · theses.fr (ABES) · doi:10.70675/fc216760z171az42f4zade0z7695e77ea077
Ahmadi, Y. E. (2020) · theses.fr (ABES) · doi:10.70675/cd8f08aezd8ecz4711zb43czd35ef03dfd1b
Dhital, R., Minz, M., Minz, R. W., Anand, S., Nada, R., Singh, S., Kenwar, D. B., & Sharma, A. (2026) · Biomedicines · doi:10.3390/biomedicines14040832
“However, in humans, FoxP3 expression can be transiently induced in activated conventional CD4 + T cells, particularly under inflammatory conditions, and does not necessarily denote stable lineage commitment or suppressive function [44].”
Bonnin, E. (2022) · theses.fr (ABES) · doi:10.70675/fd80c953z7ef5z4ff7z8413z3bd284faeed4
Peroceschi, R. (2024) · theses.fr (ABES) · doi:10.70675/1253a351z345ez4a59za033z3f19256baba1
SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells
Kolb, S., Diekmann, L., Lochert, E. D., Warmuth, L., Ritter, J., Schmidtke, G., Weber, M., Hoffmann, M., List, M., Kotlarz, D., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00812-6
“The transcriptional regulator Helios has been associated with Tconv cell activation and Treg cell stability (Allan et al, 2007; Lam et al, 2022).”
Nijhuis, L., Scholman, R. C., Lalmohamed, A., Vastert, S. J., & van Loosdregt, J. (2026) · Arthritis Research & Therapy · doi:10.1186/s13075-026-03846-2
“Notably, FOXP3 expression is not restricted to Treg cells and may also be transiently induced in activated conventional CD4 ⁺ T cells [26, 55, 57, 59], which is likely the case in the present experimental setting.”
de Joode, K., Balcioglu, H. E., van Brakel, M., López-Cascales, M. T., Hurkmans, D. P., Basak, E. A., Hoop, E. O., Lamers, C. H. J., Aerts, J. G. J. V., Mathijssen, R. H. J., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag171
Galliano, I., Nardo, F., Tinti, D., Nobili, C., Montanari, P., Calvi, C., Trada, M., SANCTIS, L. D., & Bergallo, M. (2026) · Genes · doi:10.3390/genes17091065
“Furthermore, FOXP3 expression can be induced in activated conventional T cells without conferring stable regulatory function [44].”
InfluentialRegulatory T Cells Across Oral Diseases: A Narrative Review on a Functional Perspective
Katsuma, Y., Sakai, E., & Sumita, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198555
Corona-Meraz, F.-I., Martín-Márquez, B. T., Cobos-Puc, L. E., Guzmán-Alemán, E., Aguayo‐Morales, H., Hernández‐Ortega, L. D., Rosales-Gómez, R. C., Castañeda‐Arellano, R., Sandoval-García, F., & Tovar-Cuevas, A. J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198834
Regulatory T cell heterogeneity: who they are, where they come from, and where they go
Yang, F., Ikeda, Y., Guo, Z., & Bednar, K. J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1929923
“This is partially because when human conventional T cells are activated, they can temporarily upregulate CD25, FOXP3 (145), and CTLA4 (146), creating dif fi culties in distinguishing eTregs from activated conventional cells.”
Incomplete restoration of the T helper cell landscape following IL-23p19 blockade in psoriasis
Nishimura, M., Matsushima, Y., & Yamanaka, K. (2026) · Allergology International · doi:10.1016/j.alit.2026.09.009
Type I interferons and T regulatory cells : effects on development, homeostasis and function
Metidji, A. (2015) · theses.fr (ABES) · doi:10.70675/757ff6f0z8580z46a2z855ez382e0943c383
“(glucocortocoid induced TNF family-related gene/receptor) but these markers have also been shown to be expressed by activated non-regulatory T cells (116-119).”
BackgroundT Regulatory Cells and Cancer Immunotherapy
Wang, A. Y., & Levings, M. K. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-980-2_10
Self-citation
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.